Mucormycosis. A complication of critical care.
Lethal nosocomial mucormycosis developed in three previously well individuals while they were receiving intensive care for acute hemorrhagic pancreatitis, for cardiogenic shock, and for a ruptured intra-abdominal aortic aneurysm. In two cases, the condition was first seen as progressive cavitary pneumonia refractory to antibacterial therapy; Mucoraceae was identified in all three patients only at autopsy. Each patient had received large doses of corticosteroids and broad-spectrum antibiotics, and all had suffered from respiratory failure, acute renal failure with acidosis, and severe hyperglycemia in association with total parenteral nutrition. Mucoraceae should be regarded as an additional nosocomial pathogen in the setting of advanced life-support care.
D000138:Acidosis / Q000150:complications; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003422:Critical Care / Q000009:adverse effects*; D003428:Cross Infection; D006801:Humans; D006943:Hyperglycemia / Q000150:complications; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009091:Mucormycosis / Q000150:complications / Q000635:transmission*; D012128:Respiratory Distress Syndrome / Q000150:complications
D000900:Anti-Bacterial Agents; D008775:Methylprednisolone